Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Innocan Pharma Corp (INNPF)

Innocan Pharma Corp (INNPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Innocan Pharma Announces Private Placement of Units Newswire.ca - Thu Dec 19, 3:33PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete a...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024 Newswire.ca - Thu Dec 12, 3:01PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs Newswire.ca - Tue Nov 26, 3:01PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma Reports Third Quarter 2024 Financial Results Newswire.ca - Wed Nov 20, 3:01PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand Newswire.ca - Mon Nov 11, 3:01PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma to Present at the 2024 ThinkEquity Conference GlobeNewswire - Mon Oct 21, 8:30AM CDT

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience Newswire.ca - Wed Oct 16, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs Newswire.ca - Fri Oct 11, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide Newswire.ca - Wed Oct 9, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)
Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting Newswire.ca - Tue Sep 3, 3:00PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (-5.13%)
INNPF : 0.1568 (+0.06%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - 24 minutes ago
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot